Response to “The safety of semaglutide in patients with depression and obesity”

Robert F. Kushner*, Thomas A. Wadden

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)2218
Number of pages1
JournalObesity
Volume32
Issue number12
DOIs
StatePublished - Dec 2024

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Nutrition and Dietetics

Cite this